Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Innovent’s CDMO gets green light to make biologics at large Chinese plant
  • Manufacturing

Innovent’s CDMO gets green light to make biologics at large Chinese plant

BioSpace

The license, which Innovent's Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant's capacity to 172,000 liters.

ManufacturingRead full story

pharminent April 9, 2026 (Last updated: April 9, 2026)

BioSpace

The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Kainova expands DT 7012 trial into Europe
Next: Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Related Stories

  • Manufacturing

FUJIFILM opens new iPSC facility in Madison, US

pharminent May 21, 2026
  • Manufacturing

Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities

pharminent May 12, 2026
  • Manufacturing

Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing

pharminent May 7, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.